David J. Lundquist - Net Worth and Insider Trading
David J. Lundquist Net Worth
The estimated net worth of David J. Lundquist is at least $38,266 dollars as of 2024-09-20. David J. Lundquist is the Director of Lumos Pharma Inc and owns about 9,737 shares of Lumos Pharma Inc (LUMO) stock worth over $38,266. Details can be seen in David J. Lundquist's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David J. Lundquist has not made any transactions after 2011-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David J. Lundquist
David J. Lundquist Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J. Lundquist owns 1 companies in total, including Lumos Pharma Inc (LUMO) .
Click here to see the complete history of David J. Lundquist’s form 4 insider trades.
Insider Ownership Summary of David J. Lundquist
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LUMO | Lumos Pharma Inc | 2012-03-01 | director |
David J. Lundquist Latest Holdings Summary
David J. Lundquist currently owns a total of 1 stock. David J. Lundquist owns 9,737 shares of Lumos Pharma Inc (LUMO) as of November 16, 2011, with a value of $38,266.
Latest Holdings of David J. Lundquist
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LUMO | Lumos Pharma Inc | 2011-11-16 | 9,737 | 3.93 | 38,266 |
Holding Weightings of David J. Lundquist
David J. Lundquist Form 4 Trading Tracker
According to the SEC Form 4 filings, David J. Lundquist has made a total of 0 transactions in Lumos Pharma Inc (LUMO) over the past 5 years. The most-recent trade in Lumos Pharma Inc is the acquisition of 1,667 shares on November 16, 2011, which cost David J. Lundquist around $105,000.
Insider Trading History of David J. Lundquist
- 1
David J. Lundquist Trading Performance
GuruFocus tracks the stock performance after each of David J. Lundquist's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J. Lundquist is 8.86%. GuruFocus also compares David J. Lundquist's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J. Lundquist within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J. Lundquist's insider trading performs compared to the benchmark.
Performance of David J. Lundquist
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8 | | | | | |
| Relative Return to S&P 500(%) | -6.61 | | | | | |
David J. Lundquist Ownership Network
David J. Lundquist Owned Company Details
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
David J. Lundquist is the director of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
David J. Lundquist Mailing Address
Above is the net worth, insider trading, and ownership report for David J. Lundquist. You might contact David J. Lundquist via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Aimes Ia 50010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
